Efficacy of surgical intervention in modern complex treatment for tuberculosis with multidrug-resistant and extensively drug-resistant pathogen
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background . One of the top priorities in phthisiology at present is the problem of tuberculosis treatment with multiple drug resistance (MDR) and extensive drug resistance (XDR) Mycobacterium tuberculosis (MBT). The unsatisfactory results of etiotropic chemotherapy associated with a large number of factors determine the need for surgical treatment. The effectiveness of surgical treatment and the advantages of using surgical techniques (in combination with chemotherapy) compared to the use of chemotherapy alone, it is currently poorly understood and undoubtedly requires research at various levels. The aim . Evaluation of the effectiveness and determination of optimal timing and risks of surgical intervention in the framework of complex treatment of tuberculosis with MDR/XDR pathogen using modern chemotherapy regimens. Materials and methods . The data on the treatment outcomes of 71 patients with MDR/XDR pathogen after surgery who received identical modern chemotherapy regimens (including bedaquiline, linezolid, fluoroquinolones, cycloserine) with a catamnesis of sufficient duration (at least 5 years) were analyzed. Results . Successful treatment outcome (cure with transfer to the III GDN or de-registration) was registered in 83.1 % (95% CI 72.6-90.2 %). One independent risk factor for an unfavorable outcome was identified - the presence of behavioral characteristics of the patient, indicating his low adherence to treatment (p = 0.014). For relapse, the only independent risk factor was taking less than 90 doses of drugs according to the treatment regimen for drug-resistant tuberculosis, including bedaquiline and linezolid before surgery (p = 0.013). Conclusion . The high efficiency of complex treatment during surgical intervention against the background of MDR/XDR-tuberculosis chemotherapy regimens with the inclusion of bedaquiline and linezolid has been shown. The priority role of working with patients' commitment to treatment for the prevention of adverse outcomes has been confirmed. The optimal duration of preoperative chemotherapy according to the “new” regimens (3 months or more) has been determined.
Fields of Study & Subjects
Tuberculosis Research and Epidemiology
Infectious Diseases and Tuberculosis
Mycobacterium research and diagnosis
Publication details
- Journal / source
- Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
- Volume
- 11
- Issue
- 1
- Pages
- 214–222
- Publication date
- 26 March 2026
- Language
- EN